Molecular insight into wound healing

Scientists have discovered a critical protein involved in skin inflammation. Published in Genes & Development, this study sheds new light on the molecular mechanism of wound healing and identifies a potential new drug target in the treatment of skin disorders like psoriasis.

The epidermis is the fist line of defense against injury and infection. When an injury is incurred, it is usually associated with skin inflammation. Dr. Walter Wahli and colleagues at the University of Lausanne in Basel, Switzerland have determined that the nuclear receptor protein PPARbeta (peroxisome proliferator-activated receptor beta) functions as a critical gene regulator in the cellular response to inflammation.

Upon injury, specialized epidermal cells called keratinocytes receive inflammatory signals that induce keratinocyte differentiation and migration to the site of injury, where they initiate the wound healing process. Dr. Wahli and colleagues have discovered that these inflammatory signals actually promote PPARbeta expression and the PPARbeta protein, in turn, activates the genes responsible for keratinocyte differentiation.

Dr. Wahli found that mice lacking PPARbeta are deficient in wound healing because there are an insufficient number of keratinocytes at the injury site. According to this study, PPARbeta functions by converting the inflammatory signal at the cell surface into an organized pattern of gene expression that enables keratinocytes to respond appropriately to injury.

In addition to wound healing, PPARbeta may be involved in other processes that involve inflammation-induced keratinocyte differentiation, like psoriasis. Further research will delineate the role of PPARbeta in such disorders and determine the utility of PPARbeta from a therapeutic perspective.


Contact: Nora Poppito
Cold Spring Harbor Laboratory

Page: 1

Related biology news :

1. Molecular motor implicated in tissue remodeling
2. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
3. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
4. Molecular staples shape a cancer killer
5. Molecular motor myosin VI moves hand over hand, researchers say
6. Molecular therapeutics advance fight against brain cancer
7. Molecular motor shuttles key protein in response to light
8. Molecular traffic cop directs cellular signals
9. Molecular marker predicts success of breast cancer treatment
10. Molecular image of genotoxin reveals how bacteria damage human DNA
11. Molecular mechanism found that may improve ability of stem cells to fight disease

Post Your Comments:

(Date:7/31/2018)... (PRWEB) , ... July 31, 2018 , ... GSL ... connect seamlessly with LabArchives , the leading cloud-based Electronic Lab Notebook (ELN) platform. ... LabArchives enables researchers to store all of their research data records in a secure, ...
(Date:7/28/2018)... ... 2018 , ... Inthirani Arul, an evidence-based healer, today announces research results based ... autoimmune disorders. , Biomarkers for immune function, blood, as well as, inflammation, were ... 110% increase in overall immunity as seen by the rise in antibody levels , ...
(Date:7/26/2018)... ... , ... The Conference Forum has confirmed the agenda for the 5th Annual ... the Marriott Copley Place in Boston, MA. , Daniel Karlin, MD, Head of Experimental ... to lead the discussion on how and when to implement mobile/digital technology in clinical ...
Breaking Biology News(10 mins):
(Date:7/25/2018)... (PRWEB) , ... July 25, 2018 , ... ... a biofield energy treated proprietary nutraceutical to combat inflammation and autoimmune disorders. ... as, immune function response. The following data was reported:, ...
(Date:7/24/2018)... ... 2018 , ... Mark Stutheit, an evidence-based energy healer, today ... improve anti-inflammatory, and immune function responses. , Biomarkers for systemic and organ-specific inflammation, ... reduced. Results are as follows:, , More than 40% ...
(Date:7/22/2018)... ... July 19, 2018 , ... Mitotech S.A, ... Essex Bio-Investment for Phase 3 clinical program in Dry Eye Disease. Under the ... with approximately $17m allocated towards the first Phase 3 study starting as early ...
(Date:10/12/2017)... ... October 12, 2017 , ... They call it ... biological network, a depiction of a system of linkages and connections so complex ... associate professor of computer science at Worcester Polytechnic Institute (WPI) and director of ...
Breaking Biology Technology:
Cached News: